Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction
Clinical trial NCT06510270 · UNKNOWN
Trial details
- NCT number
- NCT06510270
- Sponsor
- Aswan University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2025-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.